JMP Securities Sticks to Their Hold Rating for Adicet Bio (ACET)
Adicet Bio (ACET) Receives a Buy From Truist Financial
HC Wainwright & Co. : The Adicet Bio (ACET.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.
Adicet Bio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Precision BioSciences (DTIL) and Adicet Bio (ACET)
Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Jasper Therapeutics (JSPR) and Lucid Diagnostics (LUCD)
Wedbush: Reiterates the Adicet Bio (ACET.US) rating and adjusted from superior to superior market rating, with a target price of $5.00.
Adicet Bio Analyst Ratings
Wedbush Reiterates Outperform on Adicet Bio, Maintains $5 Price Target
Adicet Bio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Genelux Corp. (GNLX), Adicet Bio (ACET) and Entera Bio (ENTX)
Buy Rating Affirmed for Adicet Bio Amid Promising CAR T-Cell Therapies and Strong Financial Footing
Adicet Bio Analyst Ratings
JMP Securities Keeps Their Hold Rating on Adicet Bio (ACET)
JonesTrading Upgrades Adicet Bio to Buy From Hold, Price Target Is $6
Adicet Bio Shares Upgraded to Buy on Cell Therapy Catalysts
Adicet Bio Analyst Ratings
JMP Securities Sticks to Their Hold Rating for Adicet Bio (ACET)
Buy Rating on Adicet Bio Backed by Strong Clinical Data and Strategic Focus on MCL
BTIG Sticks to Its Buy Rating for Adicet Bio (ACET)
No Data